Cardiomyocyte Renewal Laboratory Archives

THI’s Cardiomyocyte Renewal Laboratory takes a closer look at the gene expression landscape of congenital heart disease Researchers in the...

Scientists Develop a Roadmap to Future Personalized Medicine for Heart Defects that Develop Before Birth HOUSTON, TX – (June...

Texas Heart Institute’s Rich Gang Li, PhD, recently earned the award for “Best Oral Presentation” for his platform talk at...

As everyone is reflecting on the year and looking forward to 2022, we celebrate the best stories, news and milestones....

The impact of a scientific article is often described in terms of how many times the article has been cited...

When Dr. Denton Cooley and his colleagues founded the Texas Heart Institute (THI), it was with the firm belief that excellence in...

When Dr. Denton Cooley and his colleagues founded the Texas Heart Institute (THI), it was with the firm belief that excellence in...

Cardiovascular disease (CVD) remains the world’s number one killer, resulting in 18.6 million deaths a year. From well-known risk factors...

The New Paper Follows Closely on the Heels of a Related Publication on Cardiomyocyte Renewal Following a Heart Attack ...

Patients suffering from heart failure have very limited treatment options, and up to this point, it had essentially been impossible...

Published in Science Translational Medicine – A Revolutionary New Game Plan for Treating Individuals Following a Heart Attack HOUSTON, TX...

Houston, TX (February 11, 2021) – The Texas Heart Institute is pleased to announce that Dr. James Martin, Director of its...